Small Cell Lung Cancer: Defining a Role for Emerging Platinum Drugs

Publisher： Karger

E-ISSN： 1423-0232|63|2|105-114

ISSN： 0030-2414

Source： Oncology, Vol.63, Iss.2, 2002-09, pp. : 105-114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of meta-analysis in defining clinical practice in advanced non-small-cell lung cancer

By Di Maio Massimo  

Clinical Investigation, Vol. 3, Iss. 6, 2013-06 ,pp. : 523-530

Future Science

Access to resources Recommend Favorite

Role of DNA Repair Gene Polymorphisms in the Efficiency of Platinum-Based Adjuvant Chemotherapy for Non-Small Cell Lung Cancer

By Mathiaux Juliette   >  

Molecular Diagnosis & Therapy, Vol. 15, Iss. 3, 2011-06 ,pp. : 159-166

Adis International

Access to resources Recommend Favorite

The Role of Irinotecan in Non-Small Cell and Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 23, Iss. 6, 2004-11 ,pp. : 25-27

Karger

Access to resources Recommend Favorite

New Drugs in the Palliative Chemotherapy of Advanced Non-Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 24, Iss. 5, 2001-10 ,pp. : 416-421

Karger

Access to resources Recommend Favorite

The Role of EGFR-TK Inhibition in Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 28, Iss. 12, 2005-12 ,pp. : 619-620

Karger

Access to resources Recommend Favorite